Outcome of Board Meeting pursuant to Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board approved audited financial results (standalone and consolidated) for FY ended March 31, 2026, with the statutory auditor (NYS & Company) issuing unmodified opinions on both. Standalone revenue from operations surged about 66% year-on-year to Rs. 10,707.20 lakhs, with net profit rising around 31% to Rs. 245.50 lakhs. Consolidated revenue grew about 33% to Rs. 22,814.20 lakhs and consolidated net profit rose about 23% to Rs. 399.54 lakhs. The company raised Rs. 2,481.20 lakhs through a Rights Issue of about 2.48 crore equity shares during the year, and funds were largely used as planned for working capital, debt repayment and general corporate purposes. However, operating cash flows were deeply negative on both bases (standalone -Rs. 2,797 lakhs, consolidated -Rs. 2,741 lakhs), and the auditor flagged several Key Audit Matters around TDS non-compliance, absence of an Internal Audit report, non-compliance with PF and ESI provisions, delayed GST filings and outstanding income tax liabilities.
Strong top-line growth and higher profits are positives for shareholders, but the sharply negative operating cash flow despite accounting profits signals working capital stress. Compliance gaps flagged by the auditor (TDS, PF, ESI, GST delays, no Internal Audit report) raise governance and regulatory risk concerns that investors should track, even though the overall auditor opinion is unmodified.